| UHC Surest Medical and Drug | Tocilizumab (Actemra®, Tofidence®, & Tyenne®) Injection for Intravenous Infusion - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Treatment of Temporomandibular Joint Disorders – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| Ambetter Health Florida Clinical | Air Ambulance | 2026-03-01 |
| Ambetter Health Florida Clinical | Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention | 2026-03-01 |
| Ambetter Health Florida Clinical | Drugs of Abuse: Definitive Testing | 2026-03-01 |
| Ambetter Health Iowa Clinical | Air Ambulance | 2026-03-01 |
| Ambetter Health Iowa Clinical | Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention | 2026-03-01 |
| Ambetter Health Alabama Clinical | Air Ambulance | 2026-03-01 |
| Ambetter Health Alabama Clinical | Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention | 2026-03-01 |
| Ambetter Health Georgia Clinical | Air Ambulance | 2026-03-01 |